Analysts Offer Predictions for Prestige Consumer Healthcare Inc.’s FY2024 Earnings (NYSE:PBH)

Prestige Consumer Healthcare Inc. (NYSE:PBH) – Equities research analysts at Zacks Research raised their FY2024 EPS estimates for Prestige Consumer Healthcare in a report issued on Monday, April 22nd. Zacks Research analyst R. Department now expects that the company will earn $4.33 per share for the year, up from their prior forecast of $4.32. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.33 per share. Zacks Research also issued estimates for Prestige Consumer Healthcare’s Q4 2024 earnings at $1.14 EPS, Q4 2026 earnings at $1.20 EPS and FY2026 earnings at $4.75 EPS.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, February 8th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $1.04 by $0.02. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The firm had revenue of $282.74 million during the quarter, compared to analyst estimates of $280.25 million. During the same quarter in the prior year, the business posted $1.04 EPS. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year.

Other equities analysts also recently issued research reports about the stock. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 10th. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research note on Monday, February 12th. One equities research analyst has rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $110.00.

Prestige Consumer Healthcare Stock Up 0.2 %

Prestige Consumer Healthcare stock opened at $69.80 on Tuesday. The company has a current ratio of 3.09, a quick ratio of 1.92 and a debt-to-equity ratio of 0.75. The stock has a 50-day moving average of $70.73 and a two-hundred day moving average of $63.94. Prestige Consumer Healthcare has a one year low of $55.96 and a one year high of $75.31.

Insider Transactions at Prestige Consumer Healthcare

In related news, SVP Mary Beth Fritz sold 5,336 shares of the stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $69.00, for a total value of $368,184.00. Following the transaction, the senior vice president now owns 15,934 shares in the company, valued at approximately $1,099,446. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On Prestige Consumer Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PBH. Global Retirement Partners LLC grew its holdings in Prestige Consumer Healthcare by 22.6% during the third quarter. Global Retirement Partners LLC now owns 1,364 shares of the company’s stock worth $78,000 after acquiring an additional 251 shares during the period. SG Americas Securities LLC acquired a new position in shares of Prestige Consumer Healthcare in the 3rd quarter valued at $1,632,000. GHP Investment Advisors Inc. boosted its holdings in Prestige Consumer Healthcare by 2.1% during the third quarter. GHP Investment Advisors Inc. now owns 84,204 shares of the company’s stock worth $5,003,000 after buying an additional 1,718 shares in the last quarter. Simplicity Solutions LLC grew its position in Prestige Consumer Healthcare by 14.1% during the third quarter. Simplicity Solutions LLC now owns 6,645 shares of the company’s stock valued at $380,000 after buying an additional 820 shares during the period. Finally, Pinnacle Associates Ltd. increased its holdings in Prestige Consumer Healthcare by 0.8% in the third quarter. Pinnacle Associates Ltd. now owns 24,672 shares of the company’s stock valued at $1,411,000 after buying an additional 200 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.